miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-skin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-skin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-skin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-skin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-skin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-skin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.36 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

What Peptides Improve Mitochondrial Function? (source s1)

Explains cardiolipin binding mechanism.

Evidence type: Published research.

PubMed search results for SS-31 skin (source s2)

Confirms absence of human skin trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Improving mitochondrial function with SS-31 reverses age-associated... (source s4)

Mouse study on mitochondrial restoration.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Skin / collagen · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain 454ce0d82d8f · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
mechanistic
SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane.
sources: s1
humanlow confidence
No published human trials test SS-31 on skin-specific endpoints.
sources: s2
humanlow confidence
FDA approved elamipretide for Barth syndrome in 2025.
sources: s3
preclinicallow confidence
Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:45
SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Skin
Slug: ss-31-skin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_
it output
{
  "slug": "ss-31-skin",
  "title": "SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded",
  "body": "## What's breaking down\n\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\n\n## What the evidence actually shows\n\nPreclinical work i
e47952f77110cf53
Machine verification: /api/articles/ss-31-skin/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane."?
ask ss-31-skin claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No published human trials test SS-31 on skin-specific endpoints."?
ask ss-31-skin claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "FDA approved elamipretide for Barth syndrome in 2025."?
ask ss-31-skin claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality."?
ask ss-31-skin claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded — and what would you need me to tell you first?
ask ss-31-skin condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded (studies vs anecdotes)?
ask ss-31-skin good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…